Sensitivity analyses of apixaban dose and bleeding | Download Table
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions | SpringerLink
Direct Oral Anticoagulants are High-Risk Medications with Potentially Complex Dosing | PSNet
Target-Specific Oral Anticoagulants
Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar
Anticoagulation therapy in Atrial Fibrillation patients at high bleeding risk - It's Over 9000!
apixaban - General Practice notebook
Target-Specific Oral Anticoagulants
Peripheral Matters | Dose-Reduced Direct Oral Anticoagulants: Practical Considerations - American College of Cardiology
Anticoagulant Therapy – Options, Dosing and Risks
![PDF] Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5e1119c2e7a1bbe9164d9b7f35ded4b0bab54995/2-Table1-1.png "PDF] Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. | Semantic Scholar")
PDF] Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1. | Semantic Scholar
Xa Inhibitors - Apixaban and Rivaroxaban Oral Xa ... | GrepMed
Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation - ScienceDirect
NOAC Dose-Adjustment Recommendations in Renal Impairment and AF | Download Table
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction - ScienceDirect
Dose reduction criteria for NOACs | Download Scientific Diagram
ELIQUIS® (apixaban) dosing for NVAF patients | ELIQUIS UK
Apixaban (Eliquis) for Stroke Prevention in Atrial Fibrillation | AAFP
Ashley & Brooke Barlow PharmD on Twitter: "DOACs are ⤴️ being used for a multitude of indications, keeping the dosing difference straight can be challenging ✨ Here's a quick Infographic to remember
Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - ScienceDirect
Pattern and Impact of Off-label Underdosing of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Who are Indicated for Standard Dosing - American Journal of Cardiology
DVT Prophylaxis After Hip/Knee Surgery|ELIQUIS® (apixaban) Safety Info
ELIQUIS® (apixaban) dosing for NVAF patients | ELIQUIS UK
Can a Single Measurement of Apixaban Levels Identify Patients at Risk of Overexposure? A Prospective Cohort Study
Table 1 from Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical
JCM | Free Full-Text | Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
Eliquis Full Prescribing Information, Dosage & Side Effects | MIMS Indonesia
ELIQUIS® (apixaban) dosing | patients with renal or hepatic impairment | ELIQUIS IRELAND
